<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03430440</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-1152</org_study_id>
    <nct_id>NCT03430440</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Effects According to Patient-controlled Epidural Analgesia Modes in Patients Undergoing Open Gastrectomy</brief_title>
  <official_title>Comparison of Analgesic Effects According to Patient-controlled Epidural Analgesia Modes in Patients Undergoing Open Gastrectomy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidural PCA (patient controlled analgesia) for post-operative pain management are effective
      analgesic method. It is widely used in the postoperative pain management for decades.

      PCA pumps typically set a fixed basal infusion rate to infuse the analgesics at a constant
      rate per every hour (conventional mode). In contrast, the newly developed computer-integrated
      patient-controlled analgesia (CIPCA) mode increases or decreases the basal infusion rate with
      the use of the patient's bolus button. The CIPCA mode sets the basal infusion rate, the
      increase / decrease rate of basal rate, and the increment / decrement interval. If the
      patient presses the bolus button within the set time interval, the set infusion rate is
      increased because the analgesic is more required. If the bolus button is not pressed during
      the set time interval, the infusion rate is decreased. Therefore, it can be said that it is
      an effective method to control the dose of analgesic agent more sensitively to changes in
      patient's needs and pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">August 21, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 21, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain (numerical rating scale: 0 ~ 10)</measure>
    <time_frame>at 6 hours postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain (numerical rating scale: 0 ~ 10)</measure>
    <time_frame>at 1, 24, and 48 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCA total dose/additional analgesic dose</measure>
    <time_frame>at 1, 6, 24, 48 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects of PCA (area and vomiting / hypotension / muscle weakness</measure>
    <time_frame>at 1, 6, 24, 48 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Open Gastrectomy With Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>CIPKA mode</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The newly developed computer-integrated patient-controlled analgesia (CIPCA) mode increases or decreases the basal infusion rate with the use of the patient's bolus button.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional mode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The conventional mode in which only the basal infusion rate is set to be fixed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Apply CIPKA mode</intervention_name>
    <description>The newly developed computer-integrated patient-controlled analgesia (CIPCA) mode increases or decreases the basal infusion rate with the use of the patient's bolus button. Compared with the conventional mode in which only the basal infusion rate is set to be fixed, the CIPCA mode sets the basal infusion rate, the increase / decrease rate of basal rate, and the increment / decrement interval.</description>
    <arm_group_label>CIPKA mode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional mode</intervention_name>
    <description>PCA pumps typically set a fixed basal infusion rate to set the analgesic to enter at a constant rate every hour (conventional mode).</description>
    <arm_group_label>Conventional mode</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. elective open gastrectomy due to stomach cancer

          2. ASA classification Ⅰ-Ⅲ

        Exclusion Criteria:

          1. hematologic clotting defect

          2. sepsis

          3. distance metastasis

          4. PCA drug (fentanyl, Ropivacaine) allergy

          5. Patients who can not read the consent form or are not fluent in Korean (illiterate,
             foreigner)

          6. pregnant, lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ki Young Lee, MD</last_name>
    <phone>82-02-2228-73997</phone>
    <email>KYLEE504@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2018</study_first_submitted>
  <study_first_submitted_qc>February 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2018</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

